Deoleo S.A [OLE] vs Naturhouse Health [NTH] Detailed Stock Comparison
Deoleo S.A
BME
Loading...
Naturhouse Health
BME
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Deoleo S.A wins in 7 metrics, Naturhouse Health wins in 12 metrics, with 0 ties. Naturhouse Health appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Deoleo S.A | Naturhouse Health | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 19.98 | 11.63 | Naturhouse Health |
| Price-to-Book Ratio | 0.45 | 3.52 | Deoleo S.A |
| Debt-to-Equity Ratio | 33.16 | 13.48 | Naturhouse Health |
| PEG Ratio | 6.20 | 8.86 | Deoleo S.A |
| EV/EBITDA | -15.00 | 7.03 | Deoleo S.A |
| Profit Margin (TTM) | -3.00% | 19.96% | Naturhouse Health |
| Operating Margin (TTM) | 3.87% | 23.24% | Naturhouse Health |
| EBITDA Margin (TTM) | 3.87% | 23.24% | Naturhouse Health |
| Return on Equity | -12.07% | 31.65% | Naturhouse Health |
| Return on Assets (TTM) | -2.72% | 17.96% | Naturhouse Health |
| Free Cash Flow (TTM) | $3.72M | $11.22M | Naturhouse Health |
| Dividend Yield | N/A | 16.39% | N/A |
| 1-Year Return | -21.74% | 2.19% | Naturhouse Health |
| Price-to-Sales Ratio (TTM) | 0.10 | 2.26 | Deoleo S.A |
| Enterprise Value | $408.70M | $95.10M | Deoleo S.A |
| EV/Revenue Ratio | 0.44 | 1.92 | Deoleo S.A |
| Gross Profit Margin (TTM) | 54.46% | 72.07% | Naturhouse Health |
| Revenue per Share (TTM) | $2 | $1 | Deoleo S.A |
| Earnings per Share (Diluted) | $-0.06 | $0.16 | Naturhouse Health |
| Beta (Stock Volatility) | 0.67 | 0.59 | Naturhouse Health |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Deoleo S.A vs Naturhouse Health Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Deoleo S.A | -1.08% | -5.26% | -5.26% | 0.00% | -5.26% | -5.26% |
| Naturhouse Health | 0.27% | 0.54% | 1.08% | 7.47% | 5.65% | 10.65% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Deoleo S.A | -21.74% | -41.94% | -33.33% | -48.57% | -51.35% | -51.35% |
| Naturhouse Health | 2.19% | 10.00% | 26.35% | -64.04% | -62.53% | -62.53% |
Performance & Financial Health Analysis: Deoleo S.A vs Naturhouse Health
| Metric | OLE | NTH |
|---|---|---|
| Market Information | ||
| Market Cap | €93.00M | €111.51M |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 333,915 | 16,455 |
| 90 Day Avg. Volume | 337,463 | 36,666 |
| Last Close | €0.18 | €1.87 |
| 52 Week Range | €0.16 - €0.25 | €1.62 - €2.40 |
| % from 52W High | -25.81% | -22.29% |
| All-Time High | €0.50 (Nov 25, 2013) | €5.69 (Apr 27, 2015) |
| % from All-Time High | -64.00% | -67.14% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.14% | -0.02% |
| Quarterly Earnings Growth | 41.57% | 0.03% |
| Financial Health | ||
| Profit Margin (TTM) | -0.03% | 0.20% |
| Operating Margin (TTM) | 0.04% | 0.23% |
| Return on Equity (TTM) | -0.12% | 0.32% |
| Debt to Equity (MRQ) | 33.16 | 13.48 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €0.42 | €0.53 |
| Cash per Share (MRQ) | €0.05 | €0.35 |
| Operating Cash Flow (TTM) | €619,000 | €11.56M |
| Levered Free Cash Flow (TTM) | €-12,202,500 | €6.15M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 16.39% |
| Last 12-Month Dividend | €0.00 | €0.30 |
Valuation & Enterprise Metrics Analysis: Deoleo S.A vs Naturhouse Health
| Metric | OLE | NTH |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 19.98 | 11.63 |
| Forward P/E | 6.20 | 8.86 |
| PEG Ratio | 6.20 | 8.86 |
| Price to Sales (TTM) | 0.10 | 2.26 |
| Price to Book (MRQ) | 0.45 | 3.52 |
| Market Capitalization | ||
| Market Capitalization | €93.00M | €111.51M |
| Enterprise Value | €408.70M | €95.10M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.44 | 1.92 |
| Enterprise to EBITDA | -15.00 | 7.03 |
| Risk & Other Metrics | ||
| Beta | 0.67 | 0.59 |
| Book Value per Share (MRQ) | €0.42 | €0.53 |
Financial Statements Comparison: Deoleo S.A vs Naturhouse Health
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | OLE | NTH |
|---|---|---|
| Revenue/Sales | €179.11M | €12.00M |
| Cost of Goods Sold | €81.56M | €3.35M |
| Gross Profit | €97.55M | €8.65M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | €7.46M | €4.38M |
| EBITDA | €3.72M | €3.71M |
| Pre-Tax Income | €13.19M | €2.65M |
| Income Tax | €13.31M | €732,000 |
| Net Income (Profit) | €-124,000 | €1.92M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | OLE | NTH |
|---|---|---|
| Cash & Equivalents | €52.89M | €20.68M |
| Total Current Assets | €283.25M | €28.18M |
| Total Current Liabilities | €206.77M | €6.46M |
| Long-Term Debt | €83.55M | €2.16M |
| Total Shareholders Equity | €415.52M | €31.69M |
| Retained Earnings | €194.54M | €9.86M |
| Property, Plant & Equipment | N/A | €0 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | OLE | NTH |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | OLE | NTH |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 333,915 | 16,455 |
| Average Daily Volume (90 Day) | 337,463 | 36,666 |
| Shares Outstanding | 500.00M | 59.95M |
| Float Shares | 189.40M | 13.12M |
| % Held by Insiders | 0.05% | 0.79% |
| % Held by Institutions | 0.58% | 0.01% |
Dividend Analysis & Yield Comparison: Deoleo S.A vs Naturhouse Health
| Metric | OLE | NTH |
|---|---|---|
| Last 12-Month Dividend | €0.00 | €0.30 |
| Last 12-Month Dividend Yield | N/A | 16.39% |
| 3-Year Avg Annual Dividend | €0.00 | €0.20 |
| 3-Year Avg Dividend Yield | N/A | 4.29% |
| 3-Year Total Dividends | €0.00 | €0.60 |
| Ex-Dividend Date | N/A | Jul 03, 2025 |